C EGFR T790M gene variant face roughly 25 times the lung cancer risk of noncarriers, according to the largest-yet study of ...

Allon Klein, professor of systems biology in the Blavatnik Institute at Harvard Medical School, has been named a 2026 Schmidt ...

In a clinical trial, the drug, daraxonrasib, doubled survival time for patients with previously treated metastatic pancreatic ...

Approach builds on prime editing, advances journey toward universal gene therapies ...

Daley laid out the institution’s response to recent challenges from the federal government and described a path forward that ...

Study provides insights into the molecular changes that drive hypertrophic cardiomyopathy (HCM), a thickening and stiffening of heart muscle that can lead to heart failure or sudden cardiac arrest.

In studying a key cancer protein, Galit Lahav is revealing the importance of rhythm and timing in biology ...

Study suggests CDK2 inhibitors, currently being tested to slow cell growth in a few types of cancer, could be used to reduce resistance to immunotherapy across a wider range of cancers. Work ...

Researchers have discovered that mammalian genes can combine to make chimeric mRNAs, which carry the instructions to produce previously unknown, functional proteins. The first chimeric mRNA they ...

A $46 million grant from a new autism research initiative, Aligning Research to Impact Autism (ARIA), is turbocharging efforts at Harvard and Yale to understand human brain development and provide ...

Made possible through the generous support of Bristol Myers Squibb, the BMS Collaborative Research Fellowship will fund select Harvard Medical School postdoctoral fellows to pursue their boldest ...